From S=Maier%C=US%G=Gary%I=A%O=ELFSANOFI%OU1=PA01%ELF21@mcimail.com Tue May 20 12:33:16 1997
Subject: Concentration values below assay limits

Hello,

I was wondering what type of approaches you may use in including or deleting sample concentrations that are below assay quantitation limits.

In my particular case approximately 20-25% of the total number of concentration time points in my data set are below assay limits.

The details of the study are:

1. 5 dose levels and 8 subjects per dose.

2. Each dose is administered orally over a 5 day period with 4 samples collected on each day (trough, 8,12,16) and a washout to 72 hours on the last study day

3. retrospective analysis

I look forward towards reading individual comments

Gary Maier
Sanofi Pharmaceuticals

****

From lewis@c255.ucsf.edu Tue May 20 16:32:53 1997
Subject: Re: Concentration values below assay limits

I have the feeling this has been discussed before...

Briefly, BQL values can convey information, especially if they occur rather isolated in time (that is, there are no above QL levels "nearby"), and should then be included in the data analysis.

While the very best way to do so is not yet known, here is a way that works pretty well:

1. Use an error model that has an additive and proportional component; e.g.,

Y = F + F*EPS(1) + EPS(2)

2. Fix var(eps(2)) to .25*QL**2. Say QL is .5 mcg/ml, then use, e.g.,

$SIGMA .04 .0625 FIX

3. Record BQL values as QL/2; i.e., for the above example as .25.

****

From n.holford@auckland.ac.nz Tue May 20 16:57:19 1997
Subject: Re: Concentration values below assay limits

Thanks for the recipe.

But how about the rationale?

In general are you advocating var(eps(2) of f*QL*QL**2 and record BQL values as f*QL (in your example f would be 1/2)?

--

Nick Holford, Dept Pharmacology & Clinical Pharmacology
University of Auckland, Private Bag 92019, Auckland, New Zealand
email:n.holford@auckland.ac.nz tel:+64(9)373-7599x6730 fax:373-7556
http://www.phm.auckland.ac.nz/Staff/NHolford/nholford.html

****

From lewis@c255.ucsf.edu Tue May 20 17:11:08 1997
Subject: Re: Concentration values below assay limits

Basically, yes, although the formulas are actually:

1. var(eps(2)) = (f*QL)**2, where f can be taklen to be .5, but see below.

2. Record BQL values as QL/2

The rationale is

1. the CV at QL is about f*100% (many define QL to be at f=.2; f=.5 gives BQL observations even less weight and is conservative in that sense).

2. If all we know is that an observation is BQL, a reasonable ignorance assumption is that the true value is drawn from a uniform distribution with support on 0 - QL; a reasonable imputed value is then the mean of this distribution, viz., QL/2.

-LBS.

****

From ef16065@ggr.co.uk Tue May 20 23:08:03 1997
Subject: Re: Concentration values below assay limits

Lew, Nick,

Have you ever tried to use the actual concentration value determined by the assay although it was BQL ? I tried, had same estimates as with Lew's suggestion, but faster convergence. Any comment on the bioanalytical side?

Eliane

****

From n.holford@auckland.ac.nz Wed May 21 12:36:19 1997
Subject: Re: Concentration values below assay limits

Eliane,

Yes. But I have little experience.

The real issue is why is there a BQL value at all?

If you have a suitable error model you can take any "measured" value at low concs and use it in your PK analyses without having to define a BQL.

But if the conc analyst will not tell you the conc but will only tell you BQL then you must resort to 'imputation' (ie. faking the data). Try telling your conc analyst that is what you are going to do :-)

--

Nick Holford, Dept Pharmacology & Clinical Pharmacology
University of Auckland, Private Bag 92019, Auckland, New Zealand
email:n.holford@auckland.ac.nz tel:+64(9)373-7599x6730 fax:373-7556
http://www.phm.auckland.ac.nz/Staff/NHolford/nholford.html

****

From lewis Wed May 21 17:52:15 1997
Subject: Re: Concentration values below assay limits

Basically, I agree with Nick - the point is to have an error model that assigns large (relative) errors to very low values. Once this is so, the exact recorded value of the very low values is not very important. I wouldn't be surprised in your case if the "BQL" values were actually rather close to the correct values (due to the very stringent precision requirements placed on values to be reported above QL), and so the measured values were actually suppling valid PK information; hence the convergence was faster ...

****

From laarons@fs1.pa.man.ac.uk Thu May 22 05:33:07 1997
Subject: Re: Concentration values below assay limits

I don't think this is going to be much use to you but we have handled levels below the limit of quantification in the following way (the method was developed by David Lunn <d.lunn@ic.ac.uk>)

We incorporated integral contributions to the likelihood, i.e.

INTEGRAL{from y = 0 to QL} Likelihood dy

But this is difficult, obviously, because you need to integrate numerically and the support of the likelihood over this region is
unknown because it depends on theta, etc. From an MCMC perspective this is alleviated somewhat because you can integrate at each iteration, but the shape of the likelihood is still unknown - i.e. you have to make sure that your integration routine is very robust. Most existing software (except BUGS ) will not let this be done.

The logic behind the method is that samples near to the LOQ, as determined by the model and associated parameter estimates, carry
more information than those samples later in time which, according to the model, should be approaching zero. Clearly there is the possibility for model misspecification here, but arguing about model adequacy based on data below the LOQ is probably not a wise thing to do.
__________________________________________________
Leon Aarons
School of Pharmacy and Pharmaceutical Sciences
University of Manchester
Manchester, M13 9PL, U.K.
tel +44-161-275-2357
fax +44-161-275-2396
email l.aarons@man.ac.uk

****